Correlation Between Continental Aktiengesellscha and National Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Continental Aktiengesellscha and National Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Continental Aktiengesellscha and National Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Continental Aktiengesellschaft and National Health Investors, you can compare the effects of market volatilities on Continental Aktiengesellscha and National Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Continental Aktiengesellscha with a short position of National Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Continental Aktiengesellscha and National Health.

Diversification Opportunities for Continental Aktiengesellscha and National Health

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Continental and National is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Continental Aktiengesellschaft and National Health Investors in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National Health Investors and Continental Aktiengesellscha is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Continental Aktiengesellschaft are associated (or correlated) with National Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National Health Investors has no effect on the direction of Continental Aktiengesellscha i.e., Continental Aktiengesellscha and National Health go up and down completely randomly.

Pair Corralation between Continental Aktiengesellscha and National Health

Assuming the 90 days trading horizon Continental Aktiengesellschaft is expected to generate 0.73 times more return on investment than National Health. However, Continental Aktiengesellschaft is 1.36 times less risky than National Health. It trades about -0.13 of its potential returns per unit of risk. National Health Investors is currently generating about -0.24 per unit of risk. If you would invest  6,488  in Continental Aktiengesellschaft on October 6, 2024 and sell it today you would lose (134.00) from holding Continental Aktiengesellschaft or give up 2.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Continental Aktiengesellschaft  vs.  National Health Investors

 Performance 
       Timeline  
Continental Aktiengesellscha 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Continental Aktiengesellschaft are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Continental Aktiengesellscha unveiled solid returns over the last few months and may actually be approaching a breakup point.
National Health Investors 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days National Health Investors has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Continental Aktiengesellscha and National Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Continental Aktiengesellscha and National Health

The main advantage of trading using opposite Continental Aktiengesellscha and National Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Continental Aktiengesellscha position performs unexpectedly, National Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Health will offset losses from the drop in National Health's long position.
The idea behind Continental Aktiengesellschaft and National Health Investors pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements